Papillary Kidney Cancer

• Papillary Kidney Cancer is the second most common type of kidney cancer, accounting for 10-15% of all renal cell carcinomas.
• Symptoms often appear in advanced stages and can include blood in urine, flank pain, and a palpable mass.
• While the exact causes are not fully understood, genetic factors and certain inherited conditions are known risk factors.
• Treatment typically involves surgery, but targeted therapies and immunotherapies are also crucial, especially for advanced cases.
• Early diagnosis is vital for improving prognosis and expanding treatment efficacy.

What is Papillary Kidney Cancer?

Papillary Kidney Cancer is a distinct form of kidney cancer originating in the lining of the small tubes within the kidney. It is the second most common type of renal cell carcinoma (RCC), accounting for approximately 10-15% of all RCC diagnoses. This cancer is characterized by its unique microscopic appearance, featuring small, finger-like growths known as papillae.

There are two main types: Type 1, generally less aggressive and often multifocal, and Type 2, which is typically more aggressive and faster-growing. These distinctions are vital for accurate diagnosis and tailored treatment, as their biological behaviors and responses to therapy differ. According to the American Cancer Society, kidney cancer incidence rates have been stable or slightly increasing, underscoring the need for continued research and awareness.

Papillary Kidney Cancer: Symptoms & Causes

Recognizing papillary renal cell carcinoma symptoms is crucial for early detection, though many patients experience no symptoms until the cancer is advanced. When present, symptoms can include:

• Hematuria: Blood in the urine, which may be visible (gross hematuria) or only detectable under a microscope.
• Flank Pain: Persistent pain in the side or back, just below the ribs.
• Abdominal Mass: A lump or mass that can be felt in the abdomen or side.
• Fatigue: Unexplained and persistent tiredness.
• Unexplained Weight Loss: Significant weight loss without changes in diet or exercise.
• Fever: Persistent low-grade fever not caused by an infection.

The exact causes of papillary kidney cancer are not fully understood, but genetic and environmental factors play a role. Unlike clear cell RCC, which links to smoking and obesity, papillary kidney cancer is more strongly associated with inherited genetic conditions. For example, hereditary papillary renal cell carcinoma (HPRCC) is caused by MET gene mutations, increasing Type 1 risk. Other syndromes, like Birt-Hogg-Dubé, also raise the risk of papillary kidney tumors.

Papillary Kidney Cancer Treatment Options

The choice of papillary kidney cancer treatment options depends on the cancer’s stage and grade, patient health, and cancer type (1 or 2). Treatment aims to remove cancer, prevent spread, and manage symptoms. A multidisciplinary team develops a personalized plan.

Key modalities include:

• Surgery: This is the primary treatment for localized papillary kidney cancer. Options include:
  • Radical Nephrectomy: Removal of the entire kidney, adrenal gland, and surrounding lymph nodes.
  • Partial Nephrectomy: Removal of only the cancerous part of the kidney, preserving healthy kidney tissue.
• Targeted Therapy: These drugs specifically target pathways involved in cancer growth and spread. Medications like sunitinib, pazopanib, and cabozantinib are often used for advanced or metastatic papillary kidney cancer, inhibiting angiogenesis and tumor cell proliferation.
• Immunotherapy: These treatments harness the body’s own immune system to fight cancer. Immune checkpoint inhibitors, such as nivolumab or pembrolizumab, are increasingly used for advanced papillary kidney cancer by blocking proteins that prevent immune cells from attacking cancer.
• Active Surveillance: For very small, slow-growing tumors, especially in older patients or those with significant comorbidities, active surveillance (closely monitoring the tumor without immediate treatment) may be an option.

Patients should discuss all treatment approaches with their healthcare providers to understand benefits, risks, and side effects. Information on alternative or complementary therapies is supportive only and does not replace conventional medical treatment.